The status of bevacizumab in the treatment of colorectal cancer

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Josefcs
dc.contributor.authorBartoš Jiřícs
dc.date.accessioned2020-06-08T09:38:54Z
dc.date.available20-03-2019en
dc.date.available2020-06-08T09:38:54Z
dc.date.issued2018cs
dc.date.updated29-00-2019en
dc.format.extent5cs
dc.identifier.issn2464-7195cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/155561
dc.language.isoczecs
dc.publisherCurrent mediacs
dc.publisher.cityPrahacs
dc.relation.ispartofOnkologická revueen
dc.relation.ispartofseries1cs
dc.subjectcolorectal carcinomacs
dc.subjectmetastasiscs
dc.subjectangiogenesiscs
dc.subjectbevacizumabcs
dc.subjectchemotherapycs
dc.subjecttargeted therapycs
dc.titleThe status of bevacizumab in the treatment of colorectal canceren
dc.titlePostavení bevacizumabu v léčbě kolorektálního karcinomucs
local.citation.epage56-60cs
local.citation.spage56-60cs
local.identifier.publikace6165
local.relation.issue6cs
Files
Collections